
View larger version (105K):
[in a new window]
|
Fig. 6. Expression of cas represses mesodermal markers, induces endodermal markers and can change the fate of cells to an endodermal identity. (A-F) Anterior to the left, dorsal to the top. (A,D) Clonal progeny of one marginal blastomere injected with gfp alone (A) or combined with cas (D) RNA at the 16-cell stage. At 24 hpf, expression of cas leads to a more frequent colonization of endodermal territories, like pharynx (arrowhead in D). (B-C, E-F) This ability to change the cell fate was confirmed by transplant experiments. By blastula stage, a few cells expressing only the gfp gene (B-C) or both gfp and cas (E-F) were transplanted to the margin of host embryos. At 24 hpf, cells expressing cas more frequently became involved in endodermal derivatives such as pharynx (E) and gut (arrowhead in F). Dorsal (G-H, O-P) and animal pole (I-L, Q-R) views of shield and 75% epiboly embryos. (G-L) Compared with the lacZ injected siblings (G,I,K), injection of cas RNA at the 8/16-cell stage induces expression of endodermal markers sox17 (H; 100%, n=23), foxa2 (J; 92%, n=12) and gata5 (L; 93%, n=15). (M,N) This induction is cell autonomous, as revealed by transplant experiments (the nuclei of grafted cells has been stained in brown by immunodetection of nuclear ß-galactosidase, used as a lineage tracer). By contrast, mesodermal markers ntl (O,P) and tbx6 (Q,R) are repressed by overexpression of cas (arrowheads in P and R; 86%, n=21 and 78%, n=18, respectively). Conversely, overexpression of ntl represses cas expression at the margin (arrowhead in T, compare with S).
|